D-dimer is a fragment left behind when the body breaks down a fibrin clot. The blood test measures how much is circulating. A normal result, read alongside clinical probability, helps rule a clot out. A raised result is nonspecific, because age, infection, surgery and many other states lift it too.
It is a small protein fragment released when an already formed, cross-linked fibrin clot is dissolved, so a measurable amount tells you that fibrin was both built and taken apart 1.
The sequence matters, because it explains why the test behaves the way it does. When a vessel wall is injured or coagulation is switched on, the enzyme thrombin converts soluble fibrinogen into fibrin strands. A second enzyme then locks those strands together into a stable mesh. Later, the fibrinolytic system activates plasmin, which chews the mesh back into soluble pieces. The smallest stable piece carries two linked D domains from neighbouring fibrin molecules, which is where the name comes from 1.
Three separate things therefore have to happen before the number on your report can rise. Thrombin has to act, the mesh has to be cross-linked, and plasmin has to break it down. That is why the marker is often described as a footprint of clot turnover rather than a picture of a clot.
Everyone has a small amount in circulation at all times, because tiny amounts of fibrin are formed and cleared continuously as part of normal vessel maintenance. The fragment clears over hours rather than minutes, so a value reflects recent fibrin turnover rather than the state of your blood in that exact second.
It matters because it is one of the few blood tests able to lower the likelihood of a blood clot enough that invasive or radiation-based imaging can sometimes be avoided. Research suggests that a negative result on a sensitive quantitative assay, combined with a low or moderate clinical probability score, makes acute deep vein thrombosis or pulmonary embolism unlikely 2.
That is a rule-out tool, not a rule-in tool. The same review found that the test has high sensitivity but limited specificity, meaning it rarely misses genuine clotting activity but flags a great many people who do not have a clot 2. In practice, a raised value is a prompt to keep investigating, not an answer in itself.
The marker also appears in other clinical settings. It forms part of the scoring systems clinicians use when widespread activation of coagulation is suspected, and it has been studied as one input into how long clot-prevention care should continue after an unexplained clot 1. Those are clinician decisions. Treatment decisions belong to a licensed provider who has reviewed your history, your imaging and your full picture.
For someone outside an emergency setting, the value of understanding this marker is mostly interpretive. If it appears on a panel and comes back above the cut-off, knowing that it is a sensitive but nonspecific signal stops a single number from becoming a conclusion.
Most laboratories do not publish a conventional two-sided range for this test. They publish a single threshold, below which a clot is considered unlikely in the right clinical context, and they report the result in one of several unit formats 3.
| How the result is reported | Common conventional threshold | What to notice |
|---|---|---|
| ng/mL FEU | around 500 ng/mL FEU | The most common format seen on reports |
| µg/mL FEU | around 0.5 µg/mL FEU | The same quantity on a different scale |
| mg/L FEU | around 0.5 mg/L FEU | The same quantity again, relabelled |
| D-dimer units (DDU) | set by the individual laboratory | Numerically lower than FEU and not interchangeable with it |
These are typical laboratory thresholds, not personal targets. Cut-offs vary by laboratory, by assay, and by the age of the person being tested, so always read a result against the range printed on that specific report.
One closely related clotting marker does have a conventional range, and FitScript reports an optimal range alongside it.
| Marker | Standard lab reference range | FitScript optimal range |
|---|---|---|
| Fibrinogen Activity | 200 to 400 mg/dL | 200 to 300 mg/dL |
FitScript optimal ranges are optimization targets, not diagnostic cut-offs. Standard reference ranges vary by laboratory, age and sex.
A normal result tells you that recent fibrin breakdown is low, which, when clinical suspicion is already low or moderate, makes an acute clot unlikely 2.
That conditional clause is the whole trick. The test is interpreted with a structured probability assessment, not on its own, because the strength of a negative result depends on how likely a clot was before the blood was drawn 1. In a person with classic one-sided leg swelling, sudden breathlessness and strong risk factors, suspicion can be high enough that imaging proceeds whatever the blood test says.
A normal value also has real limits. Very small or very distal clots, clots that formed weeks earlier and have stopped turning over, and situations where clot-prevention care is already under way can all sit alongside a value below the cut-off. Different assays differ in sensitivity, so a negative result from a less sensitive method does not carry the same weight as one from a high-sensitivity quantitative assay 3.
And a normal value says nothing about the many other causes of the symptoms that prompted the test. Chest pain and breathlessness have a long list of explanations, most of which this marker cannot see. A normal result narrows the question. It does not close it.
A high result means fibrin has been formed and broken down somewhere in the body recently. It does not say where, why, or whether a clot is present.
A raised value is associated with a long list of situations other than venous thrombosis, including increasing age, infection and inflammatory illness, recent surgery or trauma, hospitalization and immobility, cancer, liver disease, kidney impairment, pregnancy, and widespread activation of coagulation 4. Each of those involves either more fibrin being laid down, slower clearance of the fragment, or both.
That is why clinicians read the number as an observation rather than a finding. The observation is that fibrin turnover is above the laboratory threshold. The possible meanings are broad. The next step depends entirely on context, which is where a clinician comes in.
In an acute setting with symptoms that fit a clot, a value above the cut-off usually means imaging follows, because the test cannot distinguish between the possibilities on its own 1. Outside that setting, for example when the marker turns up above range on a broader panel in someone who feels well, the sensible path is a conversation that covers recent illness, recent operations, age and other markers before anyone reaches for a scan. A value that comes with symptoms is worth discussing with a clinician promptly. A single out-of-range number is suboptimal information, not a diagnosis.
Because baseline fibrin turnover tends to rise across the lifespan, a fixed threshold labels a growing share of healthy older adults as above range, which weakens the test rather than strengthening it 4.
The response has been to scale the cut-off upward for older adults instead of using one number for everyone. Research suggests that, in emergency department patients with suspected pulmonary embolism, a diagnostic strategy using a raised and age-adjusted threshold did not lead to more thromboembolic events than a conventional strategy 5. Studies indicate that age-adjusted cut-offs have also been examined specifically for ruling out deep vein thrombosis 6.
In general terms, an age-adjusted threshold means the number your laboratory considers negative is higher for a person in their seventies than for a person in their thirties. The practical consequence is that a value which looks alarming against a generic cut-off may sit comfortably inside the age-adjusted one, and that two people with identical numbers can receive genuinely different advice.
This is also why comparing your result with a friend's, or with a figure quoted online, is unreliable. The interpretation depends on your age, your assay, your units and your clinical probability. Ask the clinician reading the report which threshold they applied.
No. There is no low value that signals a problem, and laboratories do not report a lower limit of concern.
The reason sits in the biology. The fragment only exists after fibrin has been made and dismantled, so a very low or undetectable value simply reflects minimal recent clot turnover. Unlike markers where both ends of the range carry meaning, this one is a one-directional signal. In the context it was designed for, a low number is the reassuring answer.
That has a useful corollary. There is no reason to chase a lower number through diet, supplements or lifestyle changes, and no benefit has been established for doing so. Any change you see on repeat testing is far more likely to reflect what was happening in your body that week, or which assay the laboratory used, than any effort to optimize it.
What a low value does not do is rule out other clotting problems. Bleeding tendencies, platelet disorders and inherited clotting conditions are assessed with different tests entirely. A low value here is the absence of one specific signal, nothing more.
Several things can shift a result without any change in your underlying risk, and most of them are either timing or laboratory technique.
Timing matters because fibrin turnover is a moving target. A sample drawn in the days after an operation, a serious injury, a hospital stay or an acute infection can read high for reasons that have nothing to do with the symptom being investigated 4. The same is true in the opposite direction. A clot that formed some time ago may no longer be actively turning over by the time blood is taken.
Technique matters because this is an immunoassay, and immunoassays have characteristic quirks. Different manufacturers use different antibodies, different calibrators and different reporting units, and results are not freely interchangeable between methods 3. Sample handling, haemolysis and certain interfering antibodies in the blood can all affect what the analyser sees 3.
The practical takeaways are simple. Note the date of any recent surgery, injury or illness before you read a result. Keep repeat testing within one laboratory where you can. And treat a borderline value as a reason to look at the whole clinical picture rather than as a precise measurement of risk.
It is a standard venous blood draw, usually collected into a citrated tube, with the plasma run on a quantitative immunoassay or, in some urgent settings, a rapid bedside device 3.
No fasting is needed and no special preparation is required. The draw itself takes a minute or two. Because the test is built for urgent decision-making, turnaround is generally fast, and in hospital settings the result is often available within the same visit.
The report will show a number, a unit, and the threshold that laboratory applies. It is worth reading all three. The same clinical picture can produce a value of 480 or 0.48 depending on whether the laboratory reports in ng/mL FEU or µg/mL FEU, and a result quoted in D-dimer units is on a different scale again 3.
One more point on method. Quantitative assays vary in how sensitive they are, and a negative result carries more weight when it comes from a high-sensitivity method 2. If the test was run to exclude a clot, it is reasonable to ask which assay was used and which threshold was applied, because both shape what the negative result is worth.
Because there is no single universal standard for this assay, so two laboratories can report genuinely different numbers from the same sample without either being wrong 3.
The differences stack up in layers. Manufacturers raise their antibodies against different fragments of degraded fibrin. Calibration is done against different materials. Results are expressed either in fibrinogen equivalent units or in D-dimer units, which are not the same scale. On top of that, each laboratory validates its own cut-off for its own platform and population.
What this means for you is concrete. Do not convert a result from one report into the units of another and assume the comparison holds. Do not treat a number from a previous hospital visit as a baseline for a new laboratory. And if you are tracking the marker over time for any reason, keep the testing within one laboratory so the trend is meaningful.
It also means the threshold printed next to your number is not decoration. It is the only cut-off that applies to that specific result, and it is the figure a clinician will use when they interpret it.
Fibrinogen is the raw material. It is the soluble protein circulating in plasma that thrombin converts into the fibrin mesh, and the fragment measured by this test is what remains once that mesh is dismantled 1.
That relationship is why the two markers are often discussed together, and why one of the common reporting formats is expressed in fibrinogen equivalent units. Fibrinogen also behaves as an acute-phase protein, so it responds to inflammation as well as to clotting demand.
For what Fibrinogen Activity measures, how it is tested, its reference and optimal ranges, and what a high or low value may reflect, see the dedicated biomarker page.
The useful companions are the markers that describe the rest of the clotting and inflammation picture, because this fragment on its own is a single data point with many possible explanations.
Platelets are the obvious starting point, since they are the cellular half of clot formation and their count can shift in both clotting and bleeding problems. A full blood count adds red and white cell information, which can point toward infection or anaemia as a competing explanation for breathlessness. Standard clotting times describe how quickly plasma forms a clot in the tube. Inflammatory markers help place a raised value in the context of recent or ongoing illness. Kidney and liver markers matter because both organs influence how clotting proteins are produced and cleared.
This is the case for reading biomarkers as a panel rather than one at a time. FitScript's membership is built around 150+ biomarkers tested per year, with interpretation by Atlas, FitScript's AI health advisor, so a single out-of-range value is read next to the markers that give it meaning rather than in isolation.
None of that replaces imaging when a clot is genuinely suspected. Blood markers describe activity. Only a scan can show a clot and say where it is.
It matters because this test detects fibrin turnover anywhere in the body, while the clinical question is almost always about location, and location is what separates the two terms.
A thrombus is a clot that forms and stays where it formed, most often in a deep leg vein. An embolus is material that has broken away and travelled, which is how a leg clot becomes a pulmonary embolism. The underlying biology is the same, so the blood marker can rise in either situation, but the number cannot tell you which one you are dealing with or which vessel is involved. For a fuller explanation of the two terms, see embolus vs thrombus.
This is also why symptoms drive urgency more than any laboratory value. One swollen, painful, warm calf points toward a vein in the leg. Sudden breathlessness, chest pain that worsens on breathing in, or coughing blood points toward the lungs. Those are emergency presentations, and they need emergency assessment regardless of what any blood test shows or how long it would take to get one.
Always, if the result was ordered because of symptoms. The test is designed to be interpreted by the person who ordered it, alongside a clinical probability assessment, and not read in isolation 1.
Seek emergency care immediately, by calling 911, for one swollen and painful leg, sudden breathlessness, chest pain, or coughing blood. Do not wait for a blood result in that situation.
Contact a clinician promptly if a value above your laboratory's threshold comes with any new symptom, if you have recently been immobile, hospitalized or had surgery, or if you have a personal or family history of clots. In people with cancer, liver disease or kidney impairment, a raised value needs interpreting against that background rather than against a generic cut-off 4.
For a value that turns up above range on a routine panel with no symptoms, the conversation is less urgent but still worth having. Useful questions include which assay and threshold were used, whether an age-adjusted cut-off applies, what was happening in your body in the weeks before the draw, and whether repeat testing or any other marker would add anything. Never ignore an out-of-range result, and never act on one alone.
This article is educational and not medical advice. Discuss your results and any treatment with a clinician or licensed provider, who is the person qualified to decide what, if anything, should happen next.
It measures a protein fragment that appears in blood after a fibrin clot has been formed and then broken down. A measurable amount means clot turnover has happened somewhere in the body. The test cannot say where that activity took place or what caused it.
No. A value above the laboratory threshold means fibrin turnover is raised, and many ordinary situations can do that, including older age, recent surgery, injury, infection and several long-term conditions. When a clot is suspected clinically, a high value usually leads to imaging, because only a scan can confirm or exclude one. Your clinician decides what the next step should be.
Most laboratories use a single threshold rather than a two-sided range, and anything below it is reported as negative. The exact figure depends on the assay, the reporting units and, in many places, your age. Always read the number against the threshold printed on your own report.
No fasting or special preparation is needed. It is a standard venous blood draw that takes a minute or two. It is helpful to tell the person taking the sample about any recent surgery, injury, hospital stay or infection, because those details change how the result is read.
Laboratories use different assays, different calibration materials and different reporting units, so the same sample can produce different numbers in different places. There is no single universal standard for this test. If you need to track the marker over time, keep the testing within one laboratory so the comparison means something.
Baseline levels of this fragment tend to drift upward with age, so a single fixed threshold flags more older people who do not have a clot. Many laboratories therefore scale the cut-off to age. Ask which threshold was applied to your result, since it changes whether the same number reads as negative or positive.
There is no low value that signals a problem, and laboratories do not report a lower limit of concern. A low or undetectable result simply means little recent clot turnover. It also does not rule out bleeding or platelet problems, which are assessed with different tests.
Contact the clinician who ordered it, promptly if you have any new symptoms such as leg swelling, breathlessness or chest pain. If those symptoms are sudden or severe, call 911 rather than waiting. A raised value on its own is information, not a diagnosis, and a licensed provider is the person who decides whether further testing or any treatment is appropriate.